zoledronic acid has been researched along with Amenorrhea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, U; Hadji, P; Kalder, M; Maskow, C; Ziller, M | 1 |
| Ahn, JH; Ahn, JS; Im, SA; Im, YH; Jung, KH; Kim, HJ; Kim, JE; Kim, SB; Kim, SY; Lee, KS; Lee, MH; Park, YH; Ro, JS | 1 |
1 trial(s) available for zoledronic acid and Amenorrhea
| Article | Year |
|---|---|
Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: a phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).
Topics: Absorptiometry, Photon; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Drug Administration Schedule; Female; Femur Neck; Humans; Imidazoles; Infusions, Intravenous; Lumbar Vertebrae; Osteoporosis; Premenopause; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome; Zoledronic Acid | 2011 |
1 other study(ies) available for zoledronic acid and Amenorrhea
| Article | Year |
|---|---|
The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Calcaneus; Case-Control Studies; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Hip; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Statistics, Nonparametric; Time Factors; Ultrasonography; Young Adult; Zoledronic Acid | 2009 |